| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Joanne Bryce last filed a Form 4 in January 2024, as Chief Financial Officer at IRON. Joanne Bryce's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Joanne Bryce's trades have earned a middling insider score of 51/100 across 5 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +1.4%.
At the last filing, the largest reported position was 23,665 shares of IRON. The IRON filings lean toward selling, a net 20,634 shares.
Joanne Bryce has 9 Form 4 filings on record from December 2022 to January 2024, all as Chief Financial Officer at Disc Medicine (IRON), 2022–2024.
The 21 reported transactions were 10 open-market sales, 8 option exercises, 2 option or other derivative awards and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $1.1M.
The largest open-market sale was 10,072 shares of IRON at an average $49.95 on June 28, 2023, about $503K. Twelve months later IRON was down 13%.
All 5 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
Shares as reported in the last Form 4 for each company; the most recent is from January 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | IRON Disc Medicine, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 2,500 | $65.22 | $163,061.50 | -50.0% | +7.7% | +10.2% | |
| Dec 5, 2023 | IRON Disc Medicine, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 2,541 | $56.00 | $142,299.07 | -50.4% | +30.3% | +13.8% | |
| Sep 1, 2023 | IRON Disc Medicine, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 1,000 | $52.99 | $52,990.00 | -44.2% | +5.1% | -3.2% | |
| Aug 1, 2023 | IRON Disc Medicine, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 4,521 | $49.91 | $225,633.07 | -78.2% | -10.2% | -14.3% | |
| Jun 28, 2023 | IRON Disc Medicine, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 10,072 | $49.95 | $503,113.87 | -88.9% | -5.4% | -13.4% |